From: Patient Blood Management improves outcome in oncologic surgery
Cumulative N = 836 | PBM− N = 389 | PBM+ N = 447 | p value | ||||
---|---|---|---|---|---|---|---|
Age (years) | 64.8 ± 13.6 | 66.9 ± 12.4 | 0.019 | ||||
Gender (m/f) (%) | 508 (63.1%) | 328 (39.2%) | 216 (55.5% | 173 (44.5%) | 292 (65.3%) | 155 (34.6%) | 0.004 |
Indication | |||||||
Hepatobiliary | 212 (25.7%) | 92 (23.7%) | 120 (26.8%) | 0.06 | |||
Pancreatic | 80 (9.5%) | 48 (12.3%) | 32 (7.1%) | 0.09 | |||
CRLM | 273 (32.6%) | 136 (35.0%) | 137 (30.6%) | 1.00 | |||
Upper GI | 99 (11.8%) | 54 (13.9%) | 45 (10.0%) | 0.42 | |||
Intestinal | 112 (13.4%) | 38 (9.8%) | 74 (16.6%) | 0.001 | |||
Primary other | 22 (2.6%) | 14 (3.6%) | 8 (1.8%) | 0.29 | |||
Metastases other | 38 (4.5%) | 7 (1.8%) | 31 (6.8%) | < 0.001 | |||
Concomitant disease | |||||||
Cardiovascular | 437 (52.6%) | 212 (54.5%) | 225 (51.0%) | 0.229 | |||
Pulmonic | 86 (10.1%) | 48 (12.3%) | 38 (8.3%) | 0.068 | |||
Endocrine | 232 (27.6%) | 97 (25.1%) | 135 (29.8%) | 0.090 | |||
Gastrointestinal | 319 (38.1%) | 178 (45.8%) | 141 (31.5%) | < 0.001 | |||
Renal | 71 (8.4%) | 24 (6.1%) | 47 (10.3%) | 0.034 | |||
Hematologic | 50 (6.0%) | 27 (7.2%) | 23 (5.0%) | 0.246 | |||
Infection | 84 (10.3%) | 38 (9.7%) | 46 (10.7%) | 0.802 | |||
Hemoglobin prior to surgery (g/dl) | 11.9 ± 2.2 | 12.5 ± 1.9 | < 0.001 | ||||
Hemoglobin before surgery normal | 139 (35.7%) | 253 (56.6%) | < 0.001 | ||||
RBCs transfused per patient | 5.5 ± 11.1 | 3.0 ± 6.9 | < 0.001 | ||||
Patients receiving at least 1 RBC | 242 (62.4%) | 180 (40.9%) | < 0.001 | ||||
Complications DC > 3a (major) | 142 (16.9%) | 70 (17.9%) | 72 (16.0%) | 0.463 |